Figures & data
Table 1. Physico-chemical properties of the studied drugs.
Figure 1. Chiral separation in a chiral medium (Method A) using the described MLC for the separation of racemic mixture of: (a is enantiomer #1, b is enantiomer # 2).
![Figure 1. Chiral separation in a chiral medium (Method A) using the described MLC for the separation of racemic mixture of: (a is enantiomer #1, b is enantiomer # 2)A:200.0μg/mLPHRB:200.0μg/mLMBVC:200.0μg/mLCTZ}Anionic based MLC (SDS)D:200.0μg/mLCTZ}Cationic based MLC (CTM).](/cms/asset/f4cd827e-60cd-4ec9-bf57-5c56e7ab5d79/tusc_a_1927399_f0001_oc.jpg)
Figure 2. Chiral separation in chiral medium (Method B) using the described HMLC for the separation of racemic mixture of 200.0 µg/mL CTZ on cellulose 1 column: (a is enantiomer #1, b is enantiomer # 2).
![Figure 2. Chiral separation in chiral medium (Method B) using the described HMLC for the separation of racemic mixture of 200.0 µg/mL CTZ on cellulose 1 column: (a is enantiomer #1, b is enantiomer # 2).](/cms/asset/ba7892de-6ed1-42ba-b18a-ce04086f52ca/tusc_a_1927399_f0002_ob.jpg)
Scheme 1. Postulation of chiral separation mechanism of PHR in achiral medium using the SDS-based mobile phase at pH 6.
![Scheme 1. Postulation of chiral separation mechanism of PHR in achiral medium using the SDS-based mobile phase at pH 6.](/cms/asset/dc2ba8d0-4a76-465c-b628-6cbacfc43452/tusc_a_1927399_f0003_oc.jpg)